Co-Diagnostics EVP Finance and Accounting Daniel Bohrer files initial beneficial ownership statement

• Co-Diagnostics EVP of Finance & Accounting Daniel Bohrer filed an initial Form 3 reporting 3,657 common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000912282-26-001269), on September 14, 2026, and is solely responsible for the information contained therein.